Sanjeev Saxena is the VP of Sales and Marketing at Sepragen Corp, specializing in innovative chromatography technologies. He is also the founder of Actis Biologics, an early gene therapy company focused on lentiviral vectors as a delivery platform and ribozyme technology. Additionally, Sanjeev founded POC Medical Systems, a company in the medical diagnostics field. With over two decades of experience in biotechnology, Sanjeev has led multiple successful ventures, focusing on advancing gene therapy, viral vector purification, and continuous biomanufacturing. His work emphasizes sustainability, efficiency, and cutting-edge technologies.